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EFA6 regulates selective polarised transport and axon
regeneration from the axon initial segment
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ABSTRACT
Central nervous system (CNS) axons lose their intrinsic ability to
regenerate upon maturity, whereas peripheral nervous system (PNS)
axons do not. A key difference between these neuronal types is their
ability to transport integrins into axons. Integrins can mediate PNS
regeneration, but are excluded from adult CNS axons along with their
Rab11 carriers. We reasoned that exclusion of the contents of Rab11
vesicles including integrins might contribute to the intrinsic inability of
CNS neurons to regenerate, and investigated this by performing laser
axotomy.We identify a novel regulator of selective axon transport and
regeneration, the ARF6 guanine-nucleotide-exchange factor (GEF)
EFA6 (also known as PSD). EFA6 exerts its effects from a location
within the axon initial segment (AIS). EFA6 does not localise at the
AIS in dorsal root ganglion (DRG) axons, and in these neurons, ARF6
activation is counteracted by an ARF GTPase-activating protein
(GAP), which is absent from the CNS, ACAP1. Depleting EFA6 from
cortical neurons permits endosomal integrin transport and enhances
regeneration, whereas overexpressing EFA6 prevents DRG
regeneration. Our results demonstrate that ARF6 is an intrinsic
regulator of regenerative capacity, implicating EFA6 as a focal
molecule linking the AIS, signalling and transport.
This article has an associated First Person interview with the first
author of the paper.
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INTRODUCTION
Axons in the brain and spinal cord do not regenerate after injury
because of a low intrinsic capacity for growth and extrinsic inhibitory
factors (Fitch andSilver, 2008;GeoffroyandZheng, 2014). Targeting
inhibitory factors can promote recovery through sprouting and
plasticity (Schwab and Strittmatter, 2014; Silver et al., 2014), but
these interventions need to be combinedwith a strategy that promotes
long-range growth to optimise functional recovery. A number of
studies have therefore focused on enhancing intrinsic regenerative
capacity. These studies have identified signalling pathways and
genetic factors that can be targeted to promote regeneration (Lindner
et al., 2013; Liu et al., 2011; Moore and Goldberg, 2011); however,
regenerated axons often fail to reach their correct targets (Pernet and
Schwab, 2014) and the cellular mechanisms downstream of these
regeneration regulators are not completely understood. Investigating
the mechanisms governing regenerative ability will help to explain
how single interventions can orchestrate the numerous changes
required to convert a dormant fibre into a dynamic structure capable of
long-range growth (Bradke et al., 2012).
Neurons in the peripheral nervous system (PNS) have a much
greater capacity for regeneration, and can regenerate over long
distances through the spinal cord if provided with an appropriate
activated integrin (Cheah et al., 2016). Integrins are adhesion
molecules that mediate PNS regeneration, but are excluded from
CNS axons after development (Andrews et al., 2016; Franssen et al.,
2015). They are transported into PNS axons in recycling endosomes
marked by the small GTPase Rab11 (which has two forms, Rab11a
and Rab11b in mammals) (Eva et al., 2010). Rab11 governs the
trafficking of many growth-promoting molecules (Solis et al., 2013;
Wojnacki and Galli, 2016), and is necessary for growth cone
function during development (Alther et al., 2016; van Bergeijk
et al., 2015). However, Rab11 is also excluded from mature CNS
axons (Franssen et al., 2015; Sheehan et al., 1996).We reasoned that
restriction of Rab11 vesicles and their contents could be a major
cause of regeneration failure, and that its reversal might be one of the
mechanisms required to convert a quiescent axon into one capable
of growth. Using a cell biology approach, we set out to determine
how integrin and Rab11 exclusion is controlled, whether it plays a
part in governing regenerative ability and how its regulation differs
in PNS versus CNS neurons.
We have previously found that several influences are responsible
for excluding integrins from CNS axons (cortical neurons),
including the axon initial segment (AIS) and a mechanism
involving dynein-dependent retrograde transport regulated by the
small GTPase ARF6 (Franssen et al., 2015). An ARF6–Rab11–
JIP3/4 (JIP3 is also known as MAPK8IP3, and JIP4 as SPAG9)
complex is known to control the direction of recycling endosome
transport (Montagnac et al., 2009). We reasoned that there may
be an ARF6 activator in the AIS that prevents axonal integrin
transport by stimulating retrograde transport, and unites these
apparently unconnected mechanisms. We aimed to identify a
single molecule that could be targeted to facilitate transport and
promote regeneration, and might function as a focal point to regulate
signalling and transport mechanisms from the AIS. This would
mean that, in the future, it might be possible to use integrins to
promote guided regeneration of CNS axons through the spinal cord,
as has already been achieved for sensory axons (Cheah et al., 2016).
Our hypothesis was that the exclusion of integrins and Rab11-
positive recycling endosomes from adult CNS axons contributes to
their inability to regenerate; that restoring the ability of CNS axons
to transport growth-promoting machinery should boost their intrinsicReceived 14 June 2017; Accepted 8 September 2017
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regenerative ability. For this work, we have used a model of
progressive regeneration failure in maturing cortical neurons validated
in our previous research (Franssen et al., 2015; Koseki et al., 2017).
We identify the AIS-enriched ARF6 guanine-nucleotide-exchange
factor (GEF) EFA6 as a key molecule controlling selective axon
transport and regenerative ability in CNS neurons. ARF6 and Rab11
function as part of a complex, with ARF6 activation regulating
transport direction (Montagnac et al., 2009). We used live-cell
imaging to determine that EFA6 regulates not only integrin transport,
but also the transport of recycling endosomes marked by Rab11.
Removing EFA6 allows transport throughout CNS axons, and
enables them to regenerate more efficiently after in vitro laser
axotomy. This led us to understand why sensory axons have a much
higher ability to regenerate than CNS neurons. In sensory neurons
there is no transport block (Andrews et al., 2016), and EFA6 is not
enriched in the initial part of axons. In these neurons, EFA6 activity is
counteracted by an ARF6 inactivator which is not present in CNS
neurons (ACAP1) and overexpressed EFA6 inhibits regeneration.
Our results demonstrate that EFA6 and ARF6 are intrinsic regulators
of regenerative capacity, and that they can be targeted to restore
transport and promote regeneration.
RESULTS
EFA6 localises to the AIS and activates axonal ARF6
The ARF6 GEF EFA6 opposes axon regeneration in C. elegans
(Chen et al., 2011) and is strongly upregulated as CNS neurons
mature and develop selective polarised transport (Choi et al., 2006).
We used immunofluorescence to examine EFA6 localisation in rat
cortical neurons differentiating in vitro. From 7 days in vitro (DIV),
EFA6 was enriched in the initial part of the axon, where it
colocalised with the AIS marker neurofascin (Fig. 1A). It was also
present at lower levels throughout the dendrites and the cell body, as
previously reported (Choi et al., 2006) (Fig. 1A,B). EFA6 is an
ARF6 GEF (Macia et al., 2001), which also regulates microtubules
in C. elegans (Chen et al., 2011). We therefore investigated whether
EFA6 was regulating ARF protein activation and/or microtubule
dynamics. To investigate EFA6 GEF activity, we visualised
activated ARF protein by using the ARF-binding domain (ABD)
of GGA3 fused to a GST tag in 14 DIV neurons. GGA3 is a clathrin-
binding protein (Hirst et al., 2000; Puertollano et al., 2001) that
interacts only with the active form of ARF proteins (Santy and
Casanova, 2001). ARF protein activation was not restricted to the
AIS; instead we found a strong signal throughout axons (Fig. 2A).
Importantly, this signal was not evident at 4 DIV (when integrins
and Rab11 are transported into cortical axons). At this stage, when
EFA6 was not enriched in the AIS, sparse vesicular structures were
observed along the axons and these diminished at growth cones
(Fig. 2B). Imaging at higher magnification confirmed that active
ARF protein was detected uniformly along axons at the later
developmental stage (14 DIV) (Fig. 2C). To determine whether
EFA6 was involved in axonal ARF protein activation in
differentiated neurons, we depleted EFA6 with shRNA (Fig. S1).
This led to a strong reduction in ARF protein activation throughout
the axon, but did not affect the total amount of ARF6 (Fig. 2D).
EFA6 preferentially activates ARF6 (Macia et al., 2001), so our
finding suggests that EFA6 functions to activate ARF6 throughout
axons, despite being restricted to the AIS. We next examined
whether rodent EFA6 regulates microtubule dynamics by live
imaging of the microtubule end-binding protein EB3–GFP (EB3 is
also known as MAPRE3), both in the AIS and throughout the axons
of neurons expressing either control or EFA6 shRNA.We found that
EB3–GFP was enriched in the AIS of control-transfected neurons,
as previously reported (Leterrier et al., 2011). Silencing EFA6 with
shRNA had no effect on this distribution (Movies 1 and 2),
suggesting that EFA6 does not affect microtubule stabilisation
within the AIS (Leterrier et al., 2011). As a result of the high density
of EB3 in the AIS, we did not detect comets here, even after
depletion of EFA6. EB3–GFP comets were detected more distally
into axons, but silencing EFA6 had no effect on either the number or
behaviour of comets (Fig. S2). These data suggest that the
developmental rise of EFA6 in the AIS leads to activation of
ARF6 throughout mature CNS axons. However, rodent EFA6 does
not regulate axonal microtubule dynamics as has been observed in
C. elegans. This is consistent with the absence of the microtubule-
binding domain in mammalian EFA6.
EFA6 directs integrins away from axons
Whereas endogenous integrins are restricted to dendrites in
differentiated CNS neurons, overexpressed integrins enter
proximal axons where they exhibit predominantly retrograde
transport. Retrograde transport is one mechanism through which
a polarised distribution can be achieved in neurons (Guo et al.,
2016; Kuijpers et al., 2016). The direction of axonal integrin
transport is regulated by ARF6 activation state, such that elevated
Fig. 1. EFA6 is enriched in the AIS.
(A) Immunolabelling of EFA6 and neurofascin in
cortical neurons (E18, plus 4 to 21 DIV). EFA6 is
expressed at low levels throughout the cell at an
early stage (E18, 4 DIV). Expression increases
with maturity, and EFA6 is enriched at the AIS
from 7 DIV onwards. EFA6 is in green colour;
pan-neurofascin is red (to identify the AIS).
Arrows indicate the AIS. Spectrum colouring
indicates the highest signal in the AIS.
(B) Quantification of mean fluorescence
intensity of EFA6 in the AIS, axon, initial dendrite
and dendrite. n=45 neurons from three separate
experiments. ***P<0.0001; n.s., not significant
(ANOVA and Bonferroni’s comparison test). All
error bars are s.e.m.
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ARF6 activation causes retrograde transport, whereas ARF6
inactivation facilitates anterograde transport (Eva et al., 2012;
Franssen et al., 2015). Removal of the chief ARF6 activator, EFA6,
should therefore facilitate anterograde integrin transport. We used
live spinning disc confocal microscopy to image and analyse axonal
integrin movement at three points (AIS, proximal and distal)
by visualising α9-integrin–GFP (this integrin promotes spinal
sensory regeneration; Cheah et al., 2016), in the presence of
EFA6 shRNA or control. Anterograde transport was almost
undetectable in control-transfected neurons. These exhibited
predominantly retrograde and static vesicles, and there was a rapid
decline in integrin levels with distance (Fig. 3A,B; Fig. S3,
Movies 3 and 4). Depleting EFA6 initiated anterograde transport,
diminished retrograde transport, and increased integrins in all
segments of the axon (mean 8.3 vesicles per section for the AIS, 7.9
for the proximal section, 7.1 for the distal section). Endogenous β1
integrin (the binding partner of integrin α9) also entered axons.
Measurement of the axon-to-dendrite ratio showed that depleting
EFA6 led to integrins being present in axons at a similar level to in
dendrites (axon-to-dendrite ratio changing from 0.24 in control-
Fig. 2. EFA6 activates ARF throughout mature CNS axons. (A) Active ARF proteins (GGA3–ABD–GST, green) in proximal axons (neurofascin in blue),
and distal axons (axon neurofilaments, red) at 14 DIV. The ellipse indicates the initial segment; arrows indicate a distal axon. (B) In young neurons (4 DIV), active
ARF is detected in sparse tubulovesicular structures throughout developing axons, which diminish at the growth cone. (C) In differentiated neurons (14 DIV)
active ARF (GGA3–ABD–GST+anti-GST) is distributed uniformly throughout axons (as indicated by immunolabelling with SMI312 for axonal neurofilaments).
(D) Active ARF and total ARF6 in axons of neurons expressing either control shRNA or shRNA targeting EFA6 (red). Active ARF or ARF6 is shown in green,
as indicated. Arrows indicate axons. Quantification of mean axonal ARFactivity and total (mean) ARF6 in neurons expressing either control or EFA6 shRNA. n=61
and 64 neurons, respectively (for active ARF), n=50 for total ARF6 quantification. ***P<0.0001 (two-tailed Student’s t-test). All error bars are s.e.m.
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transfected neurons, to 0.95 in neurons expressing EFA6 shRNA)
(Fig. 3C,D). We also quantified the mean axonal β1 integrin
fluorescence intensity, which increased from 13.4 to 37.0 (arbitrary
units, a.u.) (Fig. 3C,E). Removing the ARF6 GEF EFA6 therefore
enables anterograde integrin transport and increases integrin levels
throughout the axon.
EFA6 directs Rab11 endosomes away from axons, but does
not affect APP transport
Axonal integrins traffic via recycling endosomes marked by Rab11.
This small GTPase is necessary for growth cone function during
developmental axon growth in the CNS and involved in axon
regeneration (Eva et al., 2010; Nguyen et al., 2016; van Bergeijk
Fig. 3. Depletion of EFA6 promotes axon transport of α9 and β1 integrins. (A) Kymographs showing dynamics of α9 integrin–GFP in the AIS, proximal and
distal axon of neurons expressing control or EFA6 shRNA. (B) Quantification of α9 integrin–GFP axon transport; n=12 AIS control, 19 AIS experimental, 12
proximal control, 24 proximal experimental, 23 distal control and, 24 distal experimental, total 1024 vesicles. *P<0.05; **P<0.01; ***P<0.001 (ANOVA and
Bonferroni’s comparison test). (C) Immunolabelling of β1 integrin in neurons expressing control or EFA6 shRNA. Arrows indicate axons. (D) Quantification of
axon-to-dendrite ratio for endogenous β1 integrin after EFA6 silencing; n=67 neurons from three experiments. ***P<0.0001 (Student’s t-test). (E) Quantification of
mean axon fluorescence intensity of endogenous β1 integrin after EFA6 silencing; n=67 neurons from three experiments. ***P<0.0001 (two-tailed Student’s t-
test). All error bars are s.e.m.
3666
RESEARCH ARTICLE Journal of Cell Science (2017) 130, 3663-3675 doi:10.1242/jcs.207423
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
et al., 2015). However, it is excluded from mature CNS axons
(Franssen et al., 2015; Sheehan et al., 1996). Rab11 and ARF6
cooperate to control microtubule-based transport direction
(Montagnac et al., 2009) and axon growth (Eva et al., 2012,
2010; Suzuki et al., 2010). From its effects on integrin transport, we
reasoned that EFA6 may be pivotal in directing Rab11 away from
axons. As with integrins, some overexpressed Rab11–GFP leaks
into CNS axons (detectable as vesicular punctae), although at much
lower levels than is seen in dendrites. This allows for analysis of
axonal vesicle dynamics (Fig. 4A). In the AIS individual vesicles
Fig. 4. See next page for legend.
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could not be distinguished (Fig. 4A, AIS kymograph). Beyond the
AIS, anterograde transport was minimal in control-transfected cells,
with the majority of vesicles moving in a retrograde direction,
moving bidirectionally or remaining immobile. Overall transport
declined with distance (mean 12.3 vesicles per proximal section, 6.7
per distal section, Fig. 4B). Expressing EFA6 shRNA stimulated
anterograde transport. There was also a reduction in retrograde
transport in the proximal axon, an increase in bidirectional
movement in the distal axon, and an increase in immobile puncta
throughout the axon (Fig. 4A,B; Fig. S3B). These transport changes
permitted endogenous Rab11 to enter axons, altering the axon-to-
dendrite ratio from 0.35 to 0.94 (control versus EFA6 shRNA)
(Fig. 4C,D). We also quantified the mean axonal Rab11
fluorescence intensity, which increased from 25.2 to 70.1 a.u.
(Fig. 4C,E). EFA6 therefore functions to limit the axonal
localisation of Rab11-positive endosomes containing integrins,
and numerous other molecules. To confirm the selectivity of these
effects, we also analysed the transport of amyloid precursor protein
(APP), a molecule which targets to CNS axons (Chiba et al., 2014)
that is not normally found in Rab11 endosomes (Steuble et al.,
2012). We found no differences in APP axon transport dynamics
between neurons expressing control or EFA6 shRNA (Fig. 4E,F),
indicating that EFA6 depletion does not alter global axon transport.
EFA6 depletion enhances regeneration of CNS axons
Rab11, integrins and reduced ARF6 activity are all beneficial for
axon growth (Cheah et al., 2016; Franssen et al., 2015; van Bergeijk
et al., 2015). We therefore asked whether silencing EFA6 would
intrinsically enhance regeneration. In vitro single-cell axotomy
enables detailed study of intrinsic regenerative capacity, allowing
morphological evaluation of the regenerative response after injury
(Gomis-Rüth et al., 2014). We developed an in vitro laser axotomy
protocol for analysing the regeneration of individually axotomised
cortical neurons (Koseki et al., 2017). Embryonic day (E)18 rat
cortical neurons were cultured on glass imaging dishes, transfected
at 10 DIV, and used for experiments at 14–17DIV. We used this
system to study the effects of EFA6 depletion on regeneration of
cortical neurons after laser axotomy (Fig. 5A; Fig. S4). When
regeneration was successful, we recorded growth cone size, the time
taken to regenerate and the distance grown after regeneration (within
the experimental time frame). We recorded whether axons formed
stumps or motile end bulbs after injury when regeneration failed
(Fig. 5B,C). By 14 DIV, integrins and Rab11 are mostly excluded
from axons, and their ability to regenerate is limited (Koseki et al.,
2017). Neurons expressing EFA6 shRNA showed a substantial
increase in regeneration with 57.6% of neurons regenerating their
axons within 14 h, compared to 27.4% of neurons expressing
control shRNA (Fig. 5D–F; Movies 5 and 6). They also developed
larger growth cones, extended their axons over greater distances and
initiated regeneration more rapidly than cells expressing control
shRNA (Fig. 5D,E,H–J). EFA6 shRNA-treated neurons tended to
form motile bulbs when they failed to regenerate (84.8%), whereas
control-transfected cells tended to form immobile stumps (55%)
(Fig. 5B–E,G). Depleting EFA6 therefore raises the regenerative
capacity of differentiated cortical neurons.
ARF6 is an intrinsic regulator of regenerative capacity
As EFA6 contributes to the low regenerative capacity of CNS
neurons, we reasoned that neurons that can regenerate their axons
should either have less axonal EFA6 or a means of counteracting its
effects. In the PNS, adult dorsal root ganglion (DRG) neurons have
regenerative axons that permit integrin and Rab11 transport
(Andrews et al., 2016; Gardiner, 2011). When we examined
EFA6 in adult DRG neurons, we found remarkably high levels in
the cell body and lower levels throughout axons (Fig. 6A). We
speculated that this may be counteracted by an ARF6 inactivator and
investigated ACAP1, a known regulator of integrin trafficking that
we previously used to manipulate integrin transport in DRG axons
(Eva et al., 2012; Li et al., 2005). ACAP1 was present in adult DRG
neurons, throughout axon shafts and at growth cones, but was absent
from cortical neurons (Fig. 6A). This led us to compare ARF protein
activation in DRG and differentiated cortical neurons.We found that
ARF protein activation was evident in DRG axons, but at a lower
level than in cortical axons (Fig. 6B). This suggests that PNS axons
may be better regenerators due to expression of an ARF6
inactivator. A prediction of this hypothesis is that elevating ARF6
activation in DRG axons would inhibit regeneration. We used laser
axotomy to injure the axons of adult DRG neurons in vitro. We
examined regeneration in the presence of overexpressed GFP,
EFA6–GFP or EFA6 E242K–GFP (incompetent to activate ARF6)
(Fig. 7). Control DRG axons regenerate rapidly, so that by 2 h after
injury 68.6% of GFP-expressing axons had developed new growth
cones (Fig. 7A,C,E; Movie 7). Overexpression of EFA6 led to a
dramatic reduction in regenerative capacity, with only 19.2% of
axons regenerating growth cones (Fig. 7B,D,E; Movie 8). This
effect was primarily due to EFA6 GEF activity, as expression of
EFA6 E242K did not have the same effect, allowing 50.5% of axons
to regenerate (Fig. 7E; Fig. S5). This suggests that EFA6 opposes
regeneration principally by virtue of its GEF activity towards ARF6.
The data demonstrate that ARF6 activation state plays a central role
in regulating the regenerative capacity of DRG neurons. Taken
together with our findings in differentiated cortical neurons, our
data suggest that the activation state of ARF6 is an intrinsic regulator
of axon regeneration, responsible for the exclusion of Rab11
vesicles and their contents (integrins and other molecules) from
CNS axons.
DISCUSSION
Our data demonstrate that the exclusion of integrins and recycling
endosomes from mature CNS axons plays an important role in
limiting regenerative potential. We show that EFA6 is
developmentally upregulated and enriched in the AIS at a time
when integrin transport becomes predominantly retrograde
(Franssen et al., 2015), and neurons lose their ability to
regenerate. From its site in the initial part of the axon, EFA6
functions to activate ARF6 throughout mature axons, leading to
retrograde removal of integrins and Rab11 endosomes. Removing
Fig. 4. Depletion of EFA6 promotes axon transport of Rab11, and not APP.
(A) Kymographs showing dynamics of Rab11–GFP in the AIS, and proximal
and distal section of the axon of neurons expressing control or EFA6 shRNA.
(B) Quantification of Rab11–GFP axon transport; n=27 control proximal, 19
experimental proximal, 31 control distal, 38 experimental distal. *P<0.05;
***P<0.001 (ANOVA and Bonferroni’s comparison test). (C) Immunolabelling of
Rab11 in neurons expressing either control or EFA6 shRNA. Arrows indicate
axons. (D) Quantification of the axon-to-dendrite ratio for endogenous Rab11
after EFA6 silencing. n=71 neurons from three experiments. ***P<0.0001
(Student’s t-test). Also see the associated Fig. S2. (E) Quantification of mean
axon fluorescence intensity of endogenous β1 integrin after EFA6 silencing.
n=71 neurons from three experiments. ***P<0.0001 (two-tailed Student’s t-
test). (F) Kymographs showing dynamics of APP–GFP in the proximal and
distal axons of neurons expressing either control shRNA or shRNA targeting
EFA6. (G) Quantification of APP–GFP vesicle movements in the proximal and
distal axon n=12, 13, 17 and 17. No statistical difference was found between
neurons expressing control or EFA6 shRNA using ANOVA and Bonferroni’s
comparison test. All error bars are s.e.m.
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EFA6 restores transport and facilitates regeneration. These
phenomena are specific to CNS neurons, as EFA6 is not enriched
in the initial part of regenerative PNS axons (of sensory DRG
neurons). Sensory neurons regulate axonal ARF6 differently, by
expressing the ARF GAP ACAP1, which is absent from cortical
neurons. Overexpressing EFA6 opposes regeneration in these
neurons, principally by virtue of its GEF domain. Our findings
start to explain, at a cellular level, why PNS neurons have a better
Fig. 5. Depleting EFA6 promotes axon regeneration in CNS neurons. (A) Example of a neuron used for CNS axotomy experiments, indicating the site chosen
for laser ablation (typically >1000 µm distal, on an unbranched section of axon). The fluorescent signal is RFP expressed with control shRNA from a single
plasmid. (B) Example of regeneration failure, and formation of a stump. (C) Example of post-axotomy end bulb formed after axotomy. (D) Neuron expressing
control shRNA, showing axotomy followed by regeneration. Note the small growth cone (typically <20 µm2 and regeneration of <100 µm in 14 h). (E) Neuron
expressing EFA6 shRNA, showing axotomy followed by regeneration >100 µm in 14 h, with growth cones typically >40 µm2. (F–J) Quantification of regenerative
response of cut axons of neurons expressing either control or EFA6 shRNA. (F) Percentage of axons regenerating within a 14 h period. ***P<0.001 (Fisher’s exact
test). n=59 (control shRNA) and 63 neurons (EFA6 shRNA). (G) Percentage of failed axons with a bulb versus with a stump. **P<0.01 (Fisher’s exact test). (H)
Distance grown after regeneration. *P<0.05 (two-tailed t-test). n=17 (control shRNA) and 34 (EFA6 shRNA). (I) Area of regenerated growth cones. ***P<0.0001
(two-tailed t-test). (J) Time taken to establish a growth cone and regenerate >50 µm. n.s., not significant (two-tailed t-test). All error bars are s.e.m.
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capacity for regeneration than their CNS counterparts. The results
implicate ARF6 as an intrinsic regulator of regenerative potential,
and identify EFA6 as a novel target for promoting CNS axon
regeneration.
EFA6 activates axonal ARF to control selective polarised
transport
We have found that EFA6 activates ARF6 throughout the axon
despite being enriched in the AIS. How does EFA6 achieve ARF
protein activation over long distances? This may involve a complex
interaction with an additional ARF regulator, ARNO (also known as
CYTH2). We have previously shown that ARNO localises
throughout the axon, and that GEF-dead ARNO facilitates integrin
transport and axon growth (Franssen et al., 2015). EFA6 is known to
control a negative-positive feedback circuit between EFA6, ARF6
and ARNO. EFA6 is necessary to establish initial ARF activation,
which is consequently maintained by ARNO (Padovani et al., 2014).
In axons, the ARF activation event may be spatially regulated, with
initial activation occurring within the AIS, and subsequent activation
maintained throughout the axon by ARNO.
The AIS is primarily responsible for initiation of the action
potential, but is also involved in the polarised delivery of membrane
proteins, ensuring the correct distribution of axonal and dendritic
machinery as neurons mature (Bentley and Banker, 2016; Rasband,
2010). The molecular mechanisms through which this is achieved
are not completely understood, but are reported to involve the actin
and microtubule cytoskeleton (Arnold, 2009; Britt et al., 2016), and
dynein-dependent retrograde transport (Kuijpers et al., 2016). We
have previously found that integrins are removed from axons by
dynein-dependent retrograde transport, and that lowering ARF
activation reduces retrograde removal of integrins and allows
modest anterograde transport. We also found that removing the AIS
by silencing its central organiser, ankyrin G, also permits some
anterograde transport, but we did not understand how these
phenomena might be linked. Here, we establish a mechanism for
the removal of both integrins and Rab11 endosomes, controlled by
EFA6 from a location in the AIS. EFA6 may be localised here by
virtue of its pleckstrin homology domain, which has a high degree
of homology with that of the AIS component βIV spectrin (Derrien
et al., 2002), but further work is necessary to investigate this. Our
Fig. 6. ARF6 is regulated differently
in CNS versus PNS neurons.
(A) Cortical neurons and adult DRG
neurons immunolabelled for EFA6
(upper panels) or ACAP1 (lower
panels). Both neuronal types were
labelled and imaged identically to
allow comparison of the fluorescence
signal. Images represent two
independent immunolabelling
experiments. (B) Axons of DRG and
cortical neurons (10 DIV) labelled
with GGA3–ABD–GST to detect
active ARF protein; spectrum
colouring of the highlighted section
indicates the highest signals. The
asterisk and red colour in the CNS
panel indicate neurofascin labelling of
the AIS to identify the axon. Graph
shows quantification of mean±s.e.m.
ARF protein activation in the two axon
types. n=58 (DRG) and 60 (cortical).
***P<0.001 (two-tailed t-test).
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current data suggest a novel model for selective distribution. The
selectivity comes from the involvement of the small GTPases ARF6
and Rab11, and likely involves the adaptor molecules JIP3 and JIP4.
ARF6 forms a complex with Rab11, and the adaptor molecules JIP3
and JIP4; the activation state of ARF6 determines whether this
complex associates with dynein or kinesin, and therefore its
direction of transport (Montagnac et al., 2009). We speculate that
for the axonal transport of a molecule to be affected by ARF6,
it needs to traffic through a Rab11- and ARF6-containing
compartment, and also interact with JIP3 and JIP4. The ARF-
dependent control of entry to a specific cellular compartment is not
without precedent. A similar mechanism regulates the entry of
rhodopsin into primary cilia. In this case, a specific ARF inactivator
(ASAP1) is required to permit ARF4- and Rab11-dependent
transport (Wang et al., 2012).
Rab11, ARF6 and axon regeneration
Much is known about the mechanisms required for growth cone
formation and subsequent axon growth, but it is not understood why
these mechanisms are not recapitulated after injury in the brain or
spinal cord (Bradke et al., 2012). Our study demonstrates that the
supply of growth-promoting material in recycling endosomes is an
important factor governing regenerative potential. An axon cannot
rebuild a functional growth cone without the appropriate materials.
It is well established that integrins are important for axon growth
during development as well as for regeneration after injury in the
PNS (Gardiner, 2011; Myers et al., 2011), and it would appear that
the same can be said for Rab11-positive recycling endosomes.
These are necessary for growth cone function in CNS neurons
during development (Alther et al., 2016; van Bergeijk et al., 2015),
and now appear to participate in regeneration of CNS neurons
axotomised in vitro. Some of the functions of Rab11 during
axon growth may be due to the supply of integrins; however,
other growth-promoting molecules also traffic via Rab11,
including neurotrophin receptors (Ascano et al., 2009; Lazo et al.,
2013), and the pro-regenerative flotillin/reggie proteins (Bodrikov
et al., 2017).
Our data imply a central role for ARF6 and EFA6 in determining
the intrinsic regenerative ability of neurons. As CNS neurons
mature, EFA6 is enriched in the initial part of the axon, leading to
axonal ARF activation and retrograde removal of molecules
necessary for growth. Conversely, adult PNS neurons regenerate
better, have low levels of EFA6 in their axons and express an ARF6
inactivator, which is not found in cortical neurons (ACAP1), and
permit Rab11 and integrin transport (Eva et al., 2010).
Overexpressing EFA6 in PNS neurons leads to a reduction in
regenerative capacity [and increased retrograde transport, (Eva et al.,
2012)], while decreasing EFA6 in cortical neurons restores
regeneration. These combined results suggest that ARF6 functions
as an intrinsic regulator of regenerative capacity, governed by its
activation state. This novel finding is in keeping with a known
intrinsic regulator of regenerative potential, the tumour suppressor
PTEN. Deleting PTEN enhances regeneration in the CNS, partly
through the PI3K–AKT–mTOR pathway (Park et al., 2008). PTEN
and phosphoinositide 3-kinase (PI3K) counteract each other to
regulate the amounts of phosphatidylinositol 4,5-bisphosphate
(PIP2) and phosphatidylinositol 3,4,5-trisphosphate (PIP3). The
majority of ARF6 GEFs and GAPs are regulated downstream of
PIP2 or PIP3 (Randazzo et al., 2001), and the activity of EFA6 is
strongly elevated in the presence of PIP2 (Macia et al., 2008). It is
therefore possible that deletion of PTEN could result in less PIP2
and lowered EFA6 activity. We hypothesise that the expression
Fig. 7. EFA6 inhibits regeneration of adult DRG axons through its ARF6-activating region. (A) Cut DRG axon expressing GFP. (B) Cut DRG axon
expressing EFA6–GFP. (C) Axon from panel A showing regeneration. (D) Axon from panel B showing failure to regenerate. (E) Quantification of axon regeneration
of DRG neurons expressing either GFP (n=48), EFA6–GFP (n=44) or EFA6 E242K (EFA6 lacking the ability to activate ARF6) (n=31). *P<0.05; ***P<0.0001;
ns, not significant (Fisher’s exact test). All error bars are s.e.m.
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profile of axonal ARF regulators and the phosphoinositide
environment are crucial factors that control the axonal entry of
regenerative machinery and its subsequent insertion onto the surface
membrane. These are crucial factors that determine whether a
damaged axon can reconstruct a functional growth cone to drive
guided axon regeneration after injury.
MATERIALS AND METHODS
Neuron cultures and transfection
Primary cortical neuron cultures were prepared from embryonic day 18
(E18) Sprague Dawley rats. Neurons were dissociated with papain
(Worthington) for 8 min at 37°C, washed with HBSS and cultured in
NeuralQ® Basal Medium (AMSBio) supplemented with GS21 (AMSBio),
and glutamax (Thermo). Cells were plated on glass-bottom dishes
(Greiner) coated with poly-D-lysine. Culture dishes were incubated in
humidified chambers to prevent evaporation of culture medium, allowing
long-term culture [up to 28 days in vitro (DIV)]. DRG neuronal cultures
were obtained from adult male Sprague Dawley rats. DRGs were
incubated with 0.1% collagenase in Dulbecco’s modified Eagle’s
medium (DMEM) for 90 min at 37°C followed by 10 min in trypsin at
37°C. DRGs were dissociated by trituration in a blunted glass pipette.
Dissociated cells were then centrifuged through a layer of 15% bovine
serum albumin (BSA), washed in DMEM, and cultured on 1 µg/ml
laminin on poly-D-lysine-coated glass-bottom dishes (Greiner) in DMEM
supplemented with 10% fetal calf serum (Thermo), 1% penicillin-
streptomycin and 50 ng/ml nerve growth factor (NGF). Cortical neurons
were transfected by oscillating nano-magnetic transfection (magnefect
nano system, nanoTherics, Stoke-On-Trent, UK) as previously described
(Franssen et al., 2015). For EFA6 silencing, cells were transfected at 10
DIV, and experiments (imaging or axotomy) were performed between 14
and 17 DIV. Transfections of dissociated adult DRG neurons were
performed in situ at 1 DIV as previously described (Eva et al., 2012)
using a Cellaxess in-dish electroporator (Cellectricon).
DNA and shRNA constructs
Integrin α9 EGFP-N3 was obtained from Addgene (Addgene plasmid
#13600), deposited by Prof. Dean Sheppard (University of California,
San Francisco, CA), as previously characterised (Eva et al., 2012, 2010;
Franssen et al., 2015). cDNA encoding human Rab11a was amplified by
PCR, introducing HindIII and BamHI restriction sites, and cloned into
EGFP-C2 (Eva et al., 2010). APP–GFP was a gift from Prof. Michael
Coleman (Centre for Brain Repair, Cambridge University, UK) (Hung and
Coleman, 2016). EB3–GFP was a gift from Prof. Casper Hoogenraad
(Utrecht University, The Netherlands) (Stepanova et al., 2003). The
human EFA6 open reading frame (ORF) in pFLAG-CMV6-EFA6
(Brown et al., 2001) was a gift from Dr. Julie Donaldson (Bethesda,
MD). Human EFA6 cDNA was obtained by PCR amplification using
pFLAG-CMV6-EFA6 as a template and was digested with EcoRI and SalI
and cloned into the same sites of pEGFP-C1 (Clontech) to obtain
pEGFPC1-EFA6 (Eva et al., 2012). Rat EFA6 (NM_134370) in
pcDNA3.1-C-(k)DYK (FLAG tag) was obtained from Genscript. EFA6
E242K–GFP (Luton et al., 2004) was a gift from Frederic Luton
(Valbonne, France). EFA6 silencing was achieved using shRNA targeting
EFA6 in pRFP-C-RS (PSD gene NM_134370, targeting sequence
5′-CAGTCCTGGATTACTCGCATCAATGTGGT-3′) (Origene). Non-
effective 29-mer scrambled shRNA cassette in pRFP-C-RS vector
(Origene) was used as a control.
Antibodies
Guinea pig polyclonal EFA6A (1626; 1:400) antibody was a gift from Prof.
Eunjoon Kim (Daejeon, South Korea) and was previously characterised
(Choi et al., 2006) and used in independent studies (Raemaekers et al., 2012;
Sannerud et al., 2011). Other primary antibodies were: mouse anti-
neurofascin clone A12/18, NeuroMab (RRID:AB_10671311), 1:200; rabbit
anti-Rab11 71-5300, Thermo, 1:50; rabbit anti-ARF6 ab77581, Abcam,
1:100; rabbit anti-GST ab19256, Abcam, 1:400; mouse anti-FLAG
ab18230, Abcam, 1:750; mouse anti-β-actin ab8226, Abcam, 1:1000;
rabbit anti-tRFP ab233, Evrogen, 1:1000; anti-integrin ß1 clone EP1041Y,
04-1109, Millipore, 1:100; and anti-pan-axonal neurofilaments mouse
monoclocal SMI312, ab24574, Abcam, 1:800. ACAP1 was detected with
goat anti-centaurin β1 (ab15903, Abcam) at 1:50. Secondary antibodies
were Alexa Fluor conjugates from Thermo used at 1:1000. Secondary
antibodies for western blotting were horseradish peroxidase (HRP)
conjugates from GE Life Sciences used at 1:10,000.
Microscopy
Laser-scanning confocal microscopy was performed using a Leica
DMI4000B microscope, with laser scanning and detection achieved by a
Leica TCS SPE confocal system controlled with Leica LAS AF software.
Fluorescence and wide-field microscopy was performed using a Leica
DM6000Bwith a Leica DFC350 FX CCD camera and a Leica AF7000 with
a Hamamatsu EM CCD C9100 camera and Leica LAS AF software. Leica
AF7000 was also used for imaging of axon and growth cone regeneration
after axotomy. Live confocal imaging was performed with an Olympus
IX70 microscope using a Hamamatsu ORCA-ER CCD camera and a
PerkinElmer UltraVIEW scanner for spinning disc confocal microscopy,
controlled with MetaMorph software.
Analysis of EFA6 distribution in axons and dendrites
E18 cortical neurons were fixed at DIV 3, 7, 14 or 21 and EFA6 was
detected using the antibody described above. The axon initial segment was
located using anti-pan-neurofascin. All cultures were fixed and labelled
using identical conditions. EFA6 fluorescence intensity was measured in the
AIS and at a region >50 µm beyond the AIS, and then at similar regions in
two dendrites to give a mean dendrite figure. Images were acquired by
confocal laser-scanning microscopy using a Leica TCS SPE confocal
microscope. Identical settings were used for the acquisition of each image
using Leica LAS AF software. Z-stacks were acquired for each image,
spanning the entire depth of each neuron. GraphPad Prism was used for
statistical analysis of data using ANOVA followed by Bonferroni’s post-hoc
analysis, as indicated in the figure legends.
Axonal ARF protein activation assay
Active ARF protein was detected using a peptide derived from the active
ARF-binding domain (ABD) of GGA3 fused to a GST tag (GGA3–
ABD–GST, Thermo). Neurons were fixed for 15 min in 3%
formaldehyde (TAAB) in PBS, permeabilised with 0.1% Triton X-100
for 2 min and incubated with 20 µg/ml GGA3–ABD–GST in TBS and
1 mM EDTA overnight at 4°C. The GST tag was then detected using
rabbit anti-GST antibody (ab19256, Abcam, 1:400) and standard
immunofluorescence. Control and EFA6 shRNA-treated cultures were
fixed and labelled in parallel, using identical conditions. Axons were
analysed at 200–1000 µm distal to the cell body. Images of axons were
acquired by confocal laser-scanning microscopy using a Leica TCS SPE
confocal microscope. Initial observations were made and detection
settings were adjusted so that the pixel intensities of acquired images
were below saturation. Settings were then stored and were applied for the
identical acquisition of each image using Leica LAS AF software.
Z-stacks were acquired for each image, spanning the entire depth of each
axon. Maximum projection images were created, and used for analysis.
Lines were then traced along sections of axons to define the region of
interest, and mean pixel intensities per axon section were quantified using
the Leica LAS AF software. The acquired images were corrected for
background by subtracting an identical region of interest adjacent to the
axon being analysed. The same technique was then used for measuring
total levels of ARF6 in axons, after ARF6 immunolabelling. GraphPad
Prism was used for statistical analysis of data with a Student’s t-test, as
indicated in the figure legends.
EFA6 shRNA validation
The efficacy of shRNA targeting EFA6 (target sequence 5′-
CAGTCCTGGATTACTCGCATCAATGTGGT-3′) was confirmed by
immunofluorescence and western blotting. E18 cortical neurons were
transfected with shRNA targeting EFA6 or non-effective scramble control
shRNA at 10 DIV, fixed at 14 DIV and immunolabelled for EFA6. To
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confirm the silencing efficiency and target validity, we used an
overexpression silencing and rescue approach similar to that described
previously (Choi et al., 2006), using human EFA6 to rescue knockdown
as there are base pair differences in the equivalent human sequence
(cagtcctggatCactcgcatcaatgtAgt) compared to the rat. Preliminary
experiments found that shRNA targeting rat EFA6 had no effect on
human EFA6 expression levels in PC12 cells stably expressing human
EFA6. We did not use this to rescue silencing in primary neurons
because we found that overexpressed EFA6 localised erroneously
throughout the axon. To confirm silencing by western blotting, PC12
cells were transfected with either rat EFA6–FLAG or rat EFA6–FLAG
plus human EFA6–FLAG (as an shRNA-resistant rescue plasmid)
together with control or EFA6 shRNA, and lysates were used for
western blotting (human and rat EFA6 run at the same size on western
blots; Choi et al., 2006). Expression levels of EFA6 were determined by
immunoblotting with anti-FLAG antibody. RFP and actin were probed
for normalisation.
Analysis of microtubule dynamics using EB3–GFP
Cortical neurons were transfected at 10 DIV with EB3–GFP, and imaged at
13–15 DIV using spinning disc confocal microscopy. Images were acquired
of cell bodies and initial sections of axons, and subsequently of regions of
axons more distal into the axon (200–400 µm). Images were acquired every
second for 3 min. Kymographs were generated using MetaMorph software,
and used to quantify the dynamics of EB3 comets. Velocity, duration, length
and number of comets were measured per axon section. ANOVA analysis
confirmed there was no variation in the length of axon sections analysed.
GraphPad Prism was used for statistical analysis of data through ANOVA
and Bonferroni’s post-hoc analysis.
Live imaging of α9 integrin, Rab11 and APP for axon transport
analysis
Cortical neurons were transfected at 10 DIV with α9 integrin–GFP, Rab11–
GFP or APP–GFP together with either control or EFA6 shRNA and imaged
at 14–15 DIV using spinning disc confocal microscopy. For α9 integrin–
GFP and Rab11–GFP, sections of axons were imaged at the AIS, at a region
in the proximal part of the axon (100–300 µm from the cell body) and a
region in the distal part of the axon (>600 µm from the cell body). APP–
GFP-expressing axons were imaged at a region in the proximal part of the
axon (100–300 µm from the cell body) and a region in the distal part of the
axon (>600 µm from the cell body). Vesicles were tracked for their visible
lifetime, and analysed by kymography to classify the proportion of vesicles
classed as anterograde, retrograde, bidirectional or immobile per axon
section. This was determined as described previously (Eva et al., 2012;
Franssen et al., 2015): vesicles with a total movement less than 2 µm during
their visible lifetimes were classed as immobile. Vesicles moving in both
directions but with net movement of less than 2 µm (during their visible
lifetimes) were classed as bidirectional, even though the total movement
may have been larger. Vesicles with net movements greater than 5 µm in
either direction by the end of their visible lifetimes were classed as
anterograde or retrograde accordingly. ANOVA analysis confirmed there
was no difference in the length of axon sections analysed (mean section
lengths varied from 55 µm to 60 µm, s.e.m. 2.2–3.8). GraphPad Prism was
used for statistical analysis of data through ANOVA and Bonferroni’s post-
hoc analysis.
Measurement of axon-to-dendrite ratio for β1 integrin and Rab11
Cortical neurons were transfected at 10 DIV with either control or EFA6
shRNA and fixed at 14 DIV. These were immunolabelled for either β1
integrin or Rab11. Control- and EFA6 shRNA-treated cultures were fixed
and labelled in parallel, using identical conditions. Images were acquired by
confocal laser-scanning microscopy using a Leica TCS SPE confocal
microscope, using identical settings for each image (determined separately
for either β1 integrin or Rab11). Images were acquired at 40× to include the
cell body, dendrites and a section of axon in each image. Leica LAS AF
software was used to measure the mean fluorescence in the axon, and in two
dendrites (to give a mean dendrite measurement). A region next to each
neurite was used to subtract background fluorescence. The axon-to-dendrite
ratio was determined as the mean dendrite fluorescence intensity divided by
the axon intensity. GraphPad Prism was used for statistical analysis of data
using a Student’s t-test.
Axonal identification
Axons and/or axon initial segments were identified either by
immunolabelling of cultures with fluorescently conjugated anti-pan-
neurofascin (Franssen et al., 2015) or by morphology (axons of
transfected cells were clearly distinguishable from dendrites due to their
length and lack of spines at more mature stages). For live labelling of
neurofascin, neurons were live labelled with an Alexa-Fluor-conjugated
antibody (488, 594 or 350 nm) for 45 min at 37°C. For antibody
conjugation, the Tris-containing buffer of anti-neurofascin was first
exchanged into 0.05 M borate buffer by dialysis using a D-tube dialyser
(Novagen) and the antibody was then fluorescently labelled using a DyLight
antibody labelling kit (Thermo).
Laser axotomy of cultured neurons
Axons were severed in vitro using a 355 nm DPSL laser (Rapp
OptoElectronic, Hamburg, Germany) connected to a Leica DMI6000B
microscope. Cortical neurons were axotomised at 14–17 DIV at distances of
800–200 µm distal to the cell body on a section of axon free from branches.
In this way, axons were cut at a substantial distance from the cell body, but
not close to the end of the axon. Only highly polarised neurons (with many
dendrites and a single axon) were chosen. A single axon cut was made per
neuron. Images after axotomy were acquired every 30 min for 14 h. The
response to axotomy was recorded as regeneration or fail. Regeneration was
classed as the development of a new growth cone followed by axon
extension for a minimum of 50 µm. Fail was then classed as either bulb or
stump phenotype. Regenerated axons were analysed for the time taken to
regeneration, growth cone area and length of axon growth in the 14 h
following axotomy. Data regarding the regeneration percentage of cortical
axons was analysed by Fisher’s exact test. GraphPad Prism was used for
statistical analysis of the remaining data. Adult DRG neurons were
axotomised as described above, except that the location for axotomy was
chosen as directly before a growth cone, so as to determine the proportion of
axons that would regenerate a growth cone rapidly after injury. Data were
analysed using Fisher’s exact test.
Statistical analysis
Statistical analysis was performed throughout using Graphpad Prism.
Fisher’s exact test was calculated using Graphpad online (https://www.
graphpad.com/quickcalcs/contingency1.cfm). Data were analysed by
ANOVA with post hoc analysis, Student’s t-test and Fisher’s exact test.
Sample sizes were based on previously published data using similar
techniques. For analysis of EFA6 distribution in axons and dendrites, the
axon and two dendrites from 15 neurons were analysed, from three separate
sets of primary cultures (a total of 45 neurons). Statistical analysis was
performed using ANOVA followed by Tukey’s multiple comparison test as
indicated in the figure legends. For quantification of axonal ARF activity in
cortical neurons, 61 experimental versus 64 control were analysed, from
three separate experiments. For total axonal ARF6 quantification, 50 axons
were analysed from three experiments. For cortical versus DRG axon ARF
quantification, n=58 (DRG) versus 60 (cortical), from three separate
experiments. Data were analysed by Student’s t-test. For analysis of EB3–
GFP comets, 30 experimental versus 40 control axon sections were imaged
and analysed. Data were analysed by Student’s t-test. Quantification of α9
integrin-GFP axon transport was performed in n=12–24 neurons per
condition, from more than three experiments, analysed using ANOVA and
Bonferroni’s comparison test. Quantification of β1 integrin axon-dendrite
ratio was performed in n=72 neurons in total from three experiments,
analysed by Student’s t-test. Quantification of Rab11–GFP axon transport
was performed in n=19–27 neurons per condition from more than three
experiments. Quantification of axon-to-dendrite ratio for Rab11 was
performed in n=53 control versus 55 experimental neurons from three
experiments, analysed by Student’s t-test. Cortical neuron axon regeneration
analysis was performed in n=59 experimental versus 63 control neurons
from more than three experiments, the percentage regenerating was
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compared by Fisher’s exact test. The percentage of failed axons bulb versus
stumps, was compared by Fisher’s exact test. The distance grown after
regeneration, area of regenerated growth cones and time taken to establish a
growth cone, were each compared by Student’s t-test. Quantification of axon
regeneration of DRG neurons was performed in n=48 expressing GFP, n=44
expressing EFA6-GFP or n=31 expressing EFA6 E242K. Data were
analysed by Fisher’s exact test.
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